All data is delayed
See More

Govt awards R6bn HIV drugs contract

Nov 29 2012 15:12

(File) (Shutterstock)

Company Data


Last traded 289
Change 3
% Change 1
Cumulative volume 1816191
Market cap 0

Last Updated: 02-10-2015 at 05:00. Prices are delayed by 15 minutes. Source: McGregor BFA


Last traded 50
Change 0
% Change 1
Cumulative volume 58448
Market cap 0

Last Updated: 02-10-2015 at 05:00. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Aspen boosts profit, Asian unit robust

Aspen: Earning to between rise 18%-24%

Aspen buys GSK Aussie drugs for R2.2bn

Drug firms win R2.5bn tender

Aspen unit to buy drug portfolio from GSK

Aspen prepared to help bridge ARV shortages


Johannesburg - South Africa on Thursday awarded a R5.9bn contract to supply life-prolonging HIV medicine to 12 international and domestic firms, to deal with the country's biggest health problem.

Companies that include Aspen Pharmacare Holdings [JSE:APN], Abbott Laboratories and Adcock Ingram Holdings [JSE:AIP] would share the contract, the health department said.

The R5.9bn contract, effective from April next year, aims to increase the number of people on treatment by nearly 50%, to 2.5 million next year.

South Africa has nearly 6 million people infected with HIV - one of the heaviest caseloads in the world. It also has one of largest treatment programmes.

But drug makers are unlikely to rake in big profits from the government award, analysts have said, given the stiff competition in the bidding.

The health department said it saved R2.2bn on the new contract, which it initially expected it would cost R8.1bn.

Aspen Pharmacare, the country's biggest generic drugs maker, was awarded 20% of the contract while its closest domestic rival, Adcock Ingram was given 14%, the health department said.

Other contracts winners included Chicago-based Abbott Laboratories with 8.1%, and domestic firm Cipla Medpro South Africa [JSE:CMP] with 9%.


Follow Fin24 on Twitter and Facebook


Read Fin24’s Comments Policy publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Company Snapshot

We're talking about:


With infrastructure spending having been identified as one of the key focus areas of the National Development Plan, tradesmen will continue to play a critical role in growing the South African economy through their skills..

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

A 30% a month return on investment is:

Previous results · Suggest a vote